Gaush Meditech Ltd (FRA:F7Y)
Germany · Delayed Price · Currency is EUR 0.8050
+0.0250 (3.21%)
At close: Jul 31, 2025, 10:00 PM CET
Intra-Cellular Therapies Market Cap
Gaush Meditech has a market cap or net worth of €120.55 million as of August 1, 2025. Its market cap has decreased by -36.10% in one year.
Market Cap
120.55M
Enterprise Value
126.03M
Revenue
189.02M
Ranking
n/a
PE Ratio
9.86
Stock Price
$0.81
Market Cap Chart
Since December 12, 2022, Gaush Meditech's market cap has decreased from 928.97M to 120.55M, a decrease of -87.02%. That is a compound annual growth rate of -53.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 119.43M | -33.94% |
| Dec 31, 2024 | 180.77M | -72.09% |
| Dec 29, 2023 | 647.76M | -29.22% |
| Dec 30, 2022 | 915.15M | -1.49% |
| Dec 12, 2022 | 928.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 289.34B |
| Siemens Aktiengesellschaft | 176.66B |
| Deutsche Telekom AG | 154.36B |
| Allianz SE | 131.75B |
| Rheinmetall AG | 79.50B |
| Siemens Energy AG | 77.36B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.55B |
| Deutsche Bank Aktiengesellschaft | 54.97B |